Form4insider filings, from the source

Company · CIK 0001142790 · SIC 2833 — Medicinal Chemicals & Botanical Products

TAURIGA SCIENCES, INC. · TAUG

Insider activity reported against this company. All insider holders · On EDGAR ↗

1M3M6M1Y2YAll datashares as filed — not split-adjusted
Open-market buys & salesbuys $9,440 · 1sales $4,782 · 5net $4,658
$10k$10k$100k$100k$1M$1MbuyssalesMar 2015Jun 2015Sep 2015Dec 2015Mar 2016Jun 2016Sep 2016

Reported at this company — common stock

TradeReported (ET)InsiderSharesAvg priceTotalOwned afterΔ stakeFlags
Oct 6, 2017 PForm 4 →Oct 6, 4:33 pm EDTSeth M ShawChief Executive Officer, Director110,000,000——271,390,000— plan?
Jun 21, 2017 PForm 4 →Jun 22, 6:16 am EDTSeth M ShawChief Executive Officer, Director44,000,000——161,390,000— plan?
Jun 15, 2017 PForm 4 →Jun 16, 3:58 pm EDTSeth M ShawChief Executive Officer, Director76,000,000——117,390,000— plan?
Sep 14, 2016 SForm 4 →Sep 14, 6:26 pm EDTThomas James GrahamDirector600,000$0.0037$2,2209,327,500−6.04% plan?
Jul 8, 2016 SForm 4 →Jul 11, 8:54 pm EDTThomas James GrahamDirector72,500$0.0089$6459,927,500−0.73% plan?
Mar 30, 2016 AForm 4 →Apr 22, 2:05 pm EDTSeth M ShawChief Executive Officer, Director37,500,000——41,390,000— plan? late
Mar 30, 2016 AForm 4 →Apr 22, 2:04 pm EDTHingge HsuDirector8,000,000——9,400,000— plan? late
Mar 30, 2016 AForm 4 →Apr 22, 2:02 pm EDTThomas James GrahamDirector8,000,000——10,000,000— plan? late
Feb 4, 2016 SForm 4 →Apr 22, 2:02 pm EDTThomas James GrahamDirector169,700$0.003$5092,000,000−7.82% plan? late
Dec 9, 2015 SForm 4 →Dec 10, 6:34 pm ESTThomas James GrahamDirector137,300$0.0027$3712,115,700−6.09% plan?
Nov 9, 2015 SForm 4 →Nov 9, 5:35 pm ESTThomas James GrahamDirector247,000$0.0042$1,0372,253,000−9.88% plan?
Mar 23, 2015 PForm 4/A →Mar 30, 1:55 pm EDTStella M. SungCEO, Director800,000$0.0118$9,44026,690,000+3.09% plan?
Mar 23, 2015 PForm 4 →Mar 25, 1:47 pm EDTStella M. SungChief Executive Officer, Director800,000$0.0118$9,44023,540,000+3.52% plan? amended

Reported at this company — derivatives (options, RSUs, warrants)

No reported derivative activity in this period.